Treatment with G-CSF (*p<0.05 vs. day 0) and G-CSF/AMD (p = 0.075 vs. day 0) enhanced the MI induced mobilization of circulating WBC, without reaching statistical significance compared to the untreated group 7 days after MI (Figure 1 upper panel). Here, CSF3 is linked to age-related macular degeneration.